Medical journals — advertisements, money, regulation, rebellion and possibly retrenchment

From: Doctors in Denial


Discusses the relationship between medical journals and the pharmaceutical industry. Discusses the push back of medical journals towards the pharmaceutical industry in more recent years and explores the limitations of the actions taken to ensure the editorial independence of these important journals.


Joel Lexchin MD

JOEL LEXCHIN, MD, is an internationally-recognized expert in pharmaceutical policy. He received his MD from the University of Toronto and has spent over thirty years working as an emergency physician in the Toronto area. He taught health policy and is a Professor Emeritus in the School of Health Policy and Management at York University. He has been an advocate for change in pharmaceutical policy for thirty-five years, has appeared before numerous parliamentary committees, and has authored or co-authored over 150 articles about all aspects of how medicines are developed and used.